Spyre Therapeutics
SYRE
SYRE
70 hedge funds and large institutions have $95.8M invested in Spyre Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $158M → $95.8M (-$62M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
70
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$466K | |
| 2 | +$365K | |
| 3 | +$186K | |
| 4 |
D.E. Shaw & Co
New York
|
+$127K |
| 5 |
Renaissance Technologies
New York
|
+$111K |
Top Sellers
| 1 | -$417K | |
| 2 | -$315K | |
| 3 | -$303K | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$285K |
| 5 |
Morgan Stanley
New York
|
-$152K |